In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $16.73 in the prior trading day, Oscar Health Inc (NYSE: OSCR) closed at $18.16, up 8.55%. In other words, the price has increased by $8.55 from its previous closing price. On the day, 20.43 million shares were traded. OSCR stock price reached its highest trading level at $18.63 during the session, while it also had its lowest trading level at $17.3806.
Ratios:
Our goal is to gain a better understanding of OSCR by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $17.
Robert W. Baird Downgraded its Outperform to Neutral on July 25, 2025, while the target price for the stock was maintained at $14.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when Schlosser Mario sold 286,182 shares for $15.27 per share. The transaction valued at 4,369,999 led to the insider holds 501,148 shares of the business.
Schlosser Mario sold 105,300 shares of OSCR for $1,584,765 on Nov 12 ’25. The President of Technology & CTO now owns 501,148 shares after completing the transaction at $15.05 per share. On Nov 12 ’25, another insider, MARIO T SCHLOSSER, who serves as the Officer of the company, bought 105,300 shares for $15.05 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 5229302272 and an Enterprise Value of 2509453056. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 4.64. Its current Enterprise Value per Revenue stands at 0.222 whereas that against EBITDA is -13.934.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.89, which has changed by 0.04789388 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.80, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -0.24%, while the 200-Day Moving Average is calculated to be 13.72%.
Shares Statistics:
The stock has traded on average 17.34M shares per day over the past 3-months and 18100300 shares per day over the last 10 days, according to various share statistics. A total of 225.78M shares are outstanding, with a floating share count of 210.12M. Insiders hold about 20.62% of the company’s shares, while institutions hold 53.26% stake in the company. Shares short for OSCR as of 1763078400 were 31967820 with a Short Ratio of 1.84, compared to 1760486400 on 38385249. Therefore, it implies a Short% of Shares Outstanding of 31967820 and a Short% of Float of 13.91.
Earnings Estimates
. The current rating of Oscar Health Inc (OSCR) is the result of assessments by 7.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.62, with high estimates of $1.19 and low estimates of $0.36.
Analysts are recommending an EPS of between -$1.17 and -$1.42 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is -$0.06, with 7.0 analysts recommending between $0.44 and -$0.48.
Revenue Estimates
8 analysts predict $3.11B in revenue for. The current quarter. It ranges from a high estimate of $3.21B to a low estimate of $3.04B. As of. The current estimate, Oscar Health Inc’s year-ago sales were $2.39BFor the next quarter, 8 analysts are estimating revenue of $3.21B. There is a high estimate of $3.74B for the next quarter, whereas the lowest estimate is $2.85B.
A total of 8 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.1B, while the lowest revenue estimate was $11.93B, resulting in an average revenue estimate of $12.02B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $12.59B in the next fiscal year. The high estimate is $14.98B and the low estimate is $11.1B.
